G017-0051 Screening compound: N-(4-ethylphenyl)-1-[(2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-7-yl)sulfonyl]pyrrolidine-2-carboxamide

G017-0051 Screening compound: N-(4-ethylphenyl)-1-[(2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-7-yl)sulfonyl]pyrrolidine-2-carboxamide
G017-0051 Screening compound: N-(4-ethylphenyl)-1-[(2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-7-yl)sulfonyl]pyrrolidine-2-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G017-0051
N-(4-ethylphenyl)-1-[(2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-7-yl)sulfonyl]pyrrolidine-2-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G017-0051

Molecular Formula

C23H27N3O4S (C23 H27 N3 O4 S)

Compound Name

N-(4-ethylphenyl)-1-[(2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-7-yl)sulfonyl]pyrrolidine-2-carboxamide

IUPAC name

N-(4-ethylphenyl)-1-[(2-oxo-2345-tetrahydro-1H-1-benzazepin-7-yl)sulfonyl]pyrrolidine-2-carboxamide

SMILES

CCc(cc1)ccc1NC(C(CCC1)N1S(c(cc1)cc(CCC2)c1NC2=O)(=O)=O)=O

InChI

InChI=1S/C23H27N3O4S/c1-2-16-8-10-18(11-9-16)24-23(28)21-6-4-14-26(21)31(29,30)19-12-13-20-17(15-19)5-3-7-22(27)25-20/h8-13,15,21H,2-7,14H2,1H3,(H,24,28)(H,25,27)/t21-/m0/s1

InChI Key

CUABINKOROGHFF-NRFANRHFSA-N

MDL Number (MFCD)

MFCD14977154

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

441.55

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

2.915

Distribution Coefficient, logD

2.915

Water Solubility, LogSw

-3.56

Polar Surface Area

81.029

Acid Dissociation Constant (pKa)

11.26

Base Dissociation Constant (pKb)

-0.92

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

39.10

G017-0051 in Drug Discovery

Included in Screening Libraries

Antiviral HBV Library (10007 compounds)

Antiviral Library (67538 compounds)

Protein-Protein Interaction Library (218420 compounds)

SmartTM Library (51161 compounds)

Targeted Diversity Library (40567 compounds)

Anti-HIV1 Library (19540 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Recognition Elements PPI Library (24135 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
Mechanism of action:
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics

References: we are preparing a list of scientific research reports with G017-0051 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G017-0051?
Check Price and Availability of G017-0051, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G017-0051 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G017-0051
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G017-0051
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G017-0051 available by request